Synthesis of phosphate sodium salt prodrug of acacetin.
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Supplementary methods
Synthesis of phosphate sodium salt prodrug of acacetin.
To a solution of acacetin (Fig. 1, Compound 1, 3 g, 10.5 mM) and 4.5 mL of NEt3 (32 mM) in DMF (20 mL) at 0 o C, 3.05 g of dibenzyl phosphite (11.6 mM) in CCl4 (5.5 mL) was added dropwise and the mixture was stirred for 2 h at room temperature (22-23 o C). The mixture was evaporated and the crude product was purified by column chromatography over silica gel by using n-hex/EtOAc/ CH2Cl2 (6:1:2 v/v). After evaporating the solvent, 1.3 g of yellow solid of compound 2 ( Fig. 1 ) was obtained.
To a solution of compound 2 (2.1 g, 3.9 mM) and formic acid (0.1 mL) in MeOH (20 mL), THF (10 mL) was added with 10% Pd/C (0.2 g) at 1 atm. After stirring for 2 h, Pd/C was filtered.
The filtrate was concentrated and 1.3 g of yellow solid of compound 3 ( Fig. 1 , phosphate ester of acacetin) was obtained.
To Compound 3 (5.0 g, 549.09 mM, 1.00 Eq) in H2O (100 mL), NaHCO3 (1 M, 1.15 L, 2.10 Eq) was added drop-wise at 5°C, and then the mixture was heated to 30°C for 4h, till most of bubbles disappeared and the solution was clear. The solution was cooled to 25°C, and extracted with EtOAc (200 mL * 4) until HPLC showed the purity of the aqueous phase was more than 99%. The aqueous phase was concentrated to 50 mL, freeze-dried to give compound 4 (acacetin prodrug, 5.1 g, 92% yield, 99.1% purity) as a light yellow solid.
Aqueous solubility of the acacetin prodrug in different solutions
Water solubility of acacetin, the intermediate phosphate ester of acacetin and the acacetin prodrug were determined at room temperature in dH2O, clinically acceptable vehicles 5% glucose and saline (0.9% NaCl). A fixed amount (20 mg) of the compounds was added to different vehicles, and mixed with a vortex for 2 min. The mixture was then sonicated for 60 min and centrifuged at 12000 g for 30 min. The supernatant was collected and diluted with methanol (for acacetin, 1:1) or other solvents accordingly (phosphate ester of acacetin and acacetin prodrug, 1:10000). The diluted mixture was filtered (0.22 μm Millipore), and analyzed by HPLC (for acacetin) or UV spectrometer (for phosphate ester of acacetin and acacetin prodrug). All experiments were performed in triplicate.
The HPLC system was equipped with a C-18 column (Grace, 4.6x150mm, 5 μm) and the mobile phase was composed of a mixture of water and methanol (v/v, 3:7, with 0.2% phosphate acid) using an isocratic elution (Hitachi L2130 pump, L2200 Autosampler and L2400 Detector, Hitachi, Japan). The flow rate was 1.0 mL/min. The UV absorbance detector was set at 330 nm.
Pentamethylquercetin (50 ng/mL) was employed as an internal standard (IS fetal bovine serum and 400 g/mL G418. Cells on a coverslip were transferred to an open cell chamber (0.5 ml) mounted on the stage of an inverted microscope and superfused with Tyrode's solution at 2 mL/min. The whole cell patch-clamp technique was used as described previously. myocytes from rat hearts were enzymatically dissociated by the procedure described previously. 3 The isolated myocytes were kept in a high potassium medium at room temperature for 1 h before electrophysiological recording. 4 After whole-cell membrane current reached stable, 5 M carbachol was added to elicit IKACh in rat atrial myocytes. Current and voltage signals were low-pass filtered at 5 kHz and stored in the hard disk of an IBM compatible computer. All experiments were conducted at room temperature.
Bioconversion of acacetin prodrug in rat plasma and hepatic microsomes
Hydrolysis of acacetin prodrug was initially determined in rat plasma. The 100 L rat plasma samples containing 5 g/mL prodrug was prepared at 4 o C and then incubated in a water bath at 37 o C and continuously shaken at 60 rpm. The plasma samples were collected at 0, 5, 15, 30, 60, 120, 180, 240 and 360 min, respectively. The reaction was terminated by adding 1 mL cold methanol containing the IS solution (50 ng/mL pentamethylquercetin). The plasma treatment was described below.
Bioconversion of acacetin prodrug was also determined in rat hepatic microsomes containing high content alkaline phosphatase, 5 as described previously. 
Bioconversion of acacetin prodrug in beagle dogs
The protocol of animal experiments was approved by the Ethics Committee of Animal Care and Use for Teaching and Research of the University of Hong Kong. Acacetin prodrug (10 mg/mL in 5% glucose) was intravenously administered in beagle dogs (6 mg/kg) in 2 min.
Blood samples (~0.5 mL) were collected from the fore or hind limbs vein before and after 5, Linearity range with 1/x/x weighting was from 1~500 ng/mL. The lower limit of quantification was 0.5 ng/mL, and the limit of detection was 0.1 ng/mL for acacetin. Assay accuracy at low, medium, and high QCs was 100 ± 3.2%, 103.6 ± 2.9% and 97.5 ± 5.1%
respectively (n = 5). Samples were stable within 4 h on the auto-sampler. The peak concentration (Cmax) and time to reach Cmax (Tmax) were read directly from individual acacetin plasma concentration-time profiles. The mean values of plasma concentrations were calculated and plotted against the time points.
Pre-pharmacokinetics of acacetin in beagle dogs
The pharmacokinetic parameters were calculated using non-compartmental analysis and compartmental analysis respectively using WinNonlin®1.3 (Pharsight Co., Mountain View, CA, USA). Thus, the area under the plasma concentration-time curve (AUClast) was calculated using the linear trapezoidal method from 0 to last sampling time. The area under the plasma concentration-time curve from zero to time infinity (AUC) was calculated as + λ ⁄ , where Ct refers to the last measured concentration and λ represents the slope of the loglinear portion of the concentration time profile. The area under the respective first momenttime curve from time zero to infinity (AUMC) was calculated using the linear trapezoidal method and appropriate area extrapolation as described by Gibaldi and Perrier. Acacetin prodrug dissolved in 5% glucose was intravenously administered at 900, 810, 765, 720, 630 and 540 mg/kg through tail vein, respectively. The animals were closely observed for symptoms and mortality in 24 h. All of the surviving animals were euthanized at the end of the study, and their vital organs were individually observed for gross pathology by necropsy, and the LD50 was calculated by the Bliss method. Figure S1 1 H NMR spectra of compound 2. 
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